1. Home
  2. NKTR vs PROF Comparison

NKTR vs PROF Comparison

Compare NKTR & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • PROF
  • Stock Information
  • Founded
  • NKTR 1990
  • PROF N/A
  • Country
  • NKTR United States
  • PROF Canada
  • Employees
  • NKTR N/A
  • PROF N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • PROF Medical/Dental Instruments
  • Sector
  • NKTR Health Care
  • PROF Health Care
  • Exchange
  • NKTR Nasdaq
  • PROF Nasdaq
  • Market Cap
  • NKTR 247.9M
  • PROF 201.2M
  • IPO Year
  • NKTR 1994
  • PROF N/A
  • Fundamental
  • Price
  • NKTR $0.93
  • PROF $7.48
  • Analyst Decision
  • NKTR Strong Buy
  • PROF Strong Buy
  • Analyst Count
  • NKTR 5
  • PROF 2
  • Target Price
  • NKTR $4.50
  • PROF $11.40
  • AVG Volume (30 Days)
  • NKTR 3.0M
  • PROF 102.1K
  • Earning Date
  • NKTR 03-07-2025
  • PROF 03-06-2025
  • Dividend Yield
  • NKTR N/A
  • PROF N/A
  • EPS Growth
  • NKTR N/A
  • PROF N/A
  • EPS
  • NKTR N/A
  • PROF N/A
  • Revenue
  • NKTR $93,137,000.00
  • PROF $8,984,000.00
  • Revenue This Year
  • NKTR $12.15
  • PROF $56.56
  • Revenue Next Year
  • NKTR N/A
  • PROF $151.33
  • P/E Ratio
  • NKTR N/A
  • PROF N/A
  • Revenue Growth
  • NKTR 5.53
  • PROF 39.35
  • 52 Week Low
  • NKTR $0.63
  • PROF $5.63
  • 52 Week High
  • NKTR $1.93
  • PROF $11.42
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 53.83
  • PROF 65.75
  • Support Level
  • NKTR $0.92
  • PROF $5.63
  • Resistance Level
  • NKTR $1.08
  • PROF $6.36
  • Average True Range (ATR)
  • NKTR 0.09
  • PROF 0.36
  • MACD
  • NKTR 0.03
  • PROF 0.18
  • Stochastic Oscillator
  • NKTR 65.63
  • PROF 87.26

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: